At the pulse of the customer: Mobile order entry in pharmacies

Mavena Pharmacy Distribution relies on new module from pharmaceutical CRM provider ysura The sales force of the Swiss medical products company Mavena introduces the latest technology from the pharmaceutical specialist ysura to optimize order processing...
Read More

Pharma OTC industry meeting in Munich

Leading pharmaceutical managers discuss the digital future of pharmacy distribution Munich, November 16, 2018 – The Munich-based specialist for CRM in the pharmaceutical sector ysura GmbH has opened a new series of the established event format “Vitamin...
Read More

OTC – Mobile order entry in pharmacies

Reliable order processing and continuous customer care – these are challenging tasks, especially for smaller pharmaceutical companies in the OTC sector. In order to support sales representatives and increase product presence and market penetration,...
Read More

Whitepaper: Do you want to easily orchestrate Multichannel campaigns?

What does the successful key to campaigns look like and how do you make Multichannel measurable? Philip Debbas, Managing Director of ysura GmbH, describes this in his whitepaper. For a long time now it has not been possible to calculate that only the...
Read More

Electronic communication in pharma without an opt-in? Yes, it’s possible

The advent of GDPR has launched an industry of, lawyers, experts, consultants, speakers, many of whom warn pharmaceutical companies about the dangers of communicating with customers without an opt-in. As the consultants tend to say: without an opt-in,...
Read More

Blockchain for Pharma – hype or real?

At a recent gathering of the ysura Innovation Circle, pharma executives as well as outside specialists discussed and debated the place of Blockchain in the pharma industry. The overall consensus was that most business models that use Blockchain do not...
Read More

How to design an opt-in campaign for pharma

As GDPR approaches on 25 May 2018, pharmaceutical companies throughout Europe are scrambling to ensure that they can stay in touch with their HCPs via digital means. This is only possible if the HCP gives the pharmaceutical company explicit consent to...
Read More

News & Events


Bitte informieren Sie mich